Denmark-based Abacus Medicine is looking to raise DKK 50m through a listing on the Frankfurt Stock Exchange. In 2018, Abacus Medicine reported sales of EUR 332m with EBIT of EUR 9.9m, against sales of EUR 253m and EBIT of EUR 7.6m in 2017.
ⓘ This story was originally featured in our daily Nordic M&A Newsletter - we publish some of the newsletter content with delay through our M&A Newsletter Library
. If you would like more insights on this deal or industry then send us an email at email@example.com